In April 2024, SLB announced an agreement to acquire ChampionX in an all-stock transaction, which we think is in the best interest of shareholders. We expect the acquisition will close in early 2025.
Proton pump inhibitors (PPIs) are a group of drugs whose purpose it is to reduce stomach acid. They have been used to treat a wide of gastric acid-related illnesses for more than 30 years and are ...